medigraphic.com
ISSN 1561-3070 (Electronic)

2015, Number 3

<< Back

Rev Cub Oftal 2015; 28 (3)

Needle revision after Ahmed valve implantation in the management of Fuch´s heterochromic cyclitis

Fumero GFY, Vidal CM, Padierne GN, Piloto DI, Fernández AL, Mariño HOM

Language: Spanish
References: 43
Page: 320-330
PDF size: 146.21 Kb.


ABSTRACT

Fuch´s heterochromic cyclitis is chronic uveitis that may be asymptomatic for years or may express heretochromia just before the onset of any other sign. Glaucoma is considered one of the most difficult complications to be treated and requires multiple surgeries. Drainage devices are increasingly used as a surgical treatment option in these cases. Here is the case of a 36 years-old woman with a history of unilateral chronic uveitis in her left eye associated to cataract and decompensate glaucoma despite the medical therapy. She presented with 50 VAR visual acuity and 32 mmHg intraocular pressure. She underwent combined surgery based on phacoemulsification and S2 model Ahmed valve implantation with mitomycin C (0,2 mg/mL) for 5 minutes. The diagnosis was encapsulated filtering bleb at the 8th week of operation. Subconjuctival needle revision with one mg of subtenial bevacizumab (avastin) in the bleb area was performed. Injection was administered every other day till completion of three doses according to the institutional protocol. Eighteen months after the surgery, the intraocular pressure was 17nnHg and the best corrected visual acuity reached 95 VAR best corrected visual acuity.


REFERENCES

  1. Wakefield D, Chang JH. Epidemiology of uveítis. Int Ophthalmol Clin. 2005;45:1-13.

  2. Rodríguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer E, D´Amico AJ, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593-9.

  3. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California, the Northerm California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491-500.

  4. Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994-1995;18:293-8.

  5. Beneyto P, Fernández MJ, García A, Ibáñez M, García-Aparicio A, Morente P. Aproximación diagnóstica a la ciclitis heterocrómica de fuchs en ausencia de heterocromía. Madrid: Arch Soc Esp Oftalmol. 2007;82(6):355-9.

  6. Monteiro LG, Orefice F. Ciclite heterocrômica de Fuchs. In: Oréfice F. Uveite: clinica e cirurgia. Rio de Janeiro: Cultura Médica; 2000. p. 796-806.

  7. Fuchs E. Ueber Komplikationen der Heterochromie. Z Augenheilkd. 1906;15(3):191-212.

  8. Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138(1):46-54.

  9. Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144(3):424-8.

  10. Gordon L. Fuch’s heterochromic cyclitis: new clues regarding pathogenesis. Am J Ophthalmol. 2004;138(1):133-4.

  11. Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner- Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883-9.

  12. Mohamed Q, Zamir E. Update on Fuchs' uveitis syndrome. Curr Opin Ophthalmol. 2005;16(6):356-63.

  13. Amsler M, Verrey F. Heterochomia de Fuchs' et fragilite vasculaire. Ophthalmologica. 1945;111:177-81.

  14. Liesegang TJ. Clinical features and prognosis in Fuchs' uveitis syndrome. Arch Ophthalmol. 1982;100(10):1622-6.

  15. Melina CC, Rodrigo A, José RC, Lima R. Glaucoma secundário à iridociclite heterocrômica de Fuchs. Rio de Janeiro: Rev Bras Oftalmol. 2011;70(2):114-17.

  16. Jones NP. Glaucoma in Fuchs' Heterochromic Uveitis: etiology, management and outcome. Eye (Lond). 1991;5(6):662-855.

  17. Cantor L, Burgoyne J, Sanders S, Bhavnani V, Hoop J, Brizendine E. The effect of mitomycin C on Molteno implant surgery: A 1 year randomized, masked prospective study. J Glaucoma. 1998;7:240-6.

  18. Brancaleoni A, Sekkat L, Bouchenaki N, Herbort CP, Herbort CP. Delay in the diagnosis of Fuchs' uveitis and its deleterious consequences. Invest Ophthalmol Vis Sci. 2003;44:2381.

  19. Wang RC, Rao NA. Idiopathic and other anterior uveitis syndromes. In: Yanoff M, Duker JS. Ophtalmology. St. Louis: Mosby; 2004. p. 1209-14.

  20. Milazzo S, Turut P, Borhan M, Kheireddine A. Intraocular lens implantation in eyes with Fuchs' heterochromic iridocyclitis. J Cataract Refract Surg. 1996;22 (Suppl. 1):800-5.

  21. O'Neill D, Murray PI, Patel BC, Hamilton AM. Extracapsular cataract surgery with and without intraocular lens implantation in Fuchs heterochromic cyclitis. Ophthalmology. 1995;102(9):1362-8.

  22. Ram J, Kaushik S, Brar GS, Gupta A. Phacoemulsification in patients with Fuchs' heterochromic uveitis. J Cataract Refract Surg. 2002;28(8):1372-8.

  23. Bonfioli AA, Curi AL, Orefice F. Fuchs' heterochromic cyclitis. Semin Ophthalmol. 2005;20(3):143-6.

  24. La Hey E, de Vries J, Lengerhorst CT, Baarsma GS, Kijlstra A. Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis. Am J Ophthalmol. 1993;116(3):327-40.

  25. Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103:299-305.

  26. Broadway DC, Jester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol. 2001;85:689-95.

  27. Carrasco F, Paczka JA, Román J, Lucido ME, De los Ríos D, Sánchez Castellanos. Experiencia clínica inicial con la válvula de Ahmed: reporte de 278 casos con glaucoma incontrolable. Am J Ophthalmol. 1997 [citado 5 de abril de 2011]. Disponible en: http://www.oftalmo.com/studium/studium1997/stud97-2/b-02.htm

  28. Lai JS, Poon AS, Chua JK, Tham CC, Leung AT, Lam DS. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol. 2000;84:718-21.

  29. Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Panek WC, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;128:198-204.

  30. Pérez García R, Martínez García A. El implante valvular de Ahmed en el glaucoma complicado. Arch Soc Esp Oftalmol. 2000;75:723-8.

  31. Ayyala RS. Comparison of different biomaterials for glaucoma drainage devices. Arch Ophthalmol. 2000;118:1081-4.

  32. Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs. trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol. 2000;130:267-73.

  33. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison outcome. Ophthalmology. 2003;110:1814-21.

  34. Kook MS, Yoon J, Kim J, Lee MS. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C. Ophthalmic Surg Lasers. 2000;31:100-6.

  35. Troncoso MU. Use of tantalum implants for inducing a permanent hypotony in rabbit eyes. Am J Ophthalmol. 1949;32:499-506.

  36. Heuer DK, Lloyd MA, Abrams DA. Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology. 1992;99:512-19.

  37. Montañez FJ, Laso E, Suñer M, Amaya C. Implante de válvula de Ahmed. Nuestra experiencia 1995-2003. Madrid: Arch Soc Esp Oftalmol. 2005 [citado 5 de noviembre de 2014];80(4). Disponible en: http://dx.doi.org/10.4321/S0365-66912005000400007

  38. Boyle J, Netland P. Incisional Therapies: Shuts and valved implants. In: The glaucoma books. Springers; 2010:813-30.

  39. Ewing RH, Stamper RL. Needle revision with and without 5-fluorouracil for the treatment of failed filtering blebs. Am J Ophthalmol. 1990 [citado 5 de abril de 2014];110:254-25. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/2396649

  40. Hawkins AS, Flanagan JK, Brown SV. Predictors for success of needle revision of failing filtration blebs. Ophthalmology. 2002 [citado 5 de abril de 2014]. 109:781-85. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11927440

  41. Mardelli PG, Lederer CM, Murray PL. Slit lamp needle revision of failed filtering blebs using MMC. Ophthalmology. 1996 [citado 5 de abril de 2014]; 103(11):1946-54. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8942894

  42. Kahook MY. Needle bleb revision with bevacizumab. Techniques in Ophthalmology. 2008 [citado 5 de abril de 2011];6(4):111-3. Disponible en: http://journals.lww.com/techniques-in ophthalmology/Abstract/2008/12000/Needle_Bleb_Revision_With_Bevacizu mab.2.aspx

  43. Kahook MY, Schuman JS, Noecker RJ. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging. 2006;37(2):148-50.




2020     |     www.medigraphic.com